Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/promise-and-challenges-with-the-use-of-mobile-applications-to-support-HwGTpqEt13
References (10)
-
T. Ueno, Y. Asahina, A. Tanaka, H. Yamada, M. Nakamura, Y. Uyama (2014)
Significant Differences in Drug Lag in Clinical Development Among Various Strategies Used for Regulatory Submissions in JapanClinical Pharmacology & Therapeutics, 95
-
F. Arnold, Satoshi Fukunaga, M. Kusama, N. Matsuki, Shunsuke Ono (2014)
Assessment of Factors Associated With Dose Differences Between Japan and the United StatesClinical Pharmacology & Therapeutics, 95
-
Peter Honig, Richard Lalonde (2010)
The Economics of Drug Development: A Grim Reality and a Role for Clinical PharmacologyClinical Pharmacology & Therapeutics, 87
-
(2013)
guidance for industry and Food and Drug Administration staff -
New trend of clinical development in Japan ; from sequential bridging to simultaneous global development -
L. Dayer, S. Heldenbrand, Paul Anderson, P. Gubbins, B. Martin (2013)
Smartphone medication adherence apps: potential benefits to patients and providers.Journal of the American Pharmacists Association : JAPhA, 53 2
-
L. Dayer, S. Heldenbrand, Paul Anderson, P. Gubbins, Bradley Martin (2013)
Potential Benefits to Patients and Providers -
D. Kamerow (2013)
Regulating medical apps: which ones and how much?BMJ : British Medical Journal, 347
-
Huang Sm, Robert Temple (2008)
Is This the Drug or Dose for You?: Impact and Consideration of Ethnic Factors in Global Drug Development, Regulatory Review, and Clinical PracticeClinical Pharmacology & Therapeutics, 84
-
Mobile medical applications: guidance for industry and Food and Drug Administration staff
- Publisher
- Wiley
- Copyright
- © 2014 American Society for Clinical Pharmacology and Therapeutics
- ISSN
- 0009-9236
- eISSN
- 1532-6535
- DOI
- 10.1038/clpt.2014.34
- Publisher site
- See Article on Publisher Site
Abstract
Mobile applications represent an immense opportunity to support and improve patient health care, as the scope and functionality of medical apps are enabling physicians and patients to manage care in new, fast, and personalized ways. Several challenges exist in medical‐app development, including careful attention to quality systems, medical‐device regulation, and app life span. Despite these complexities, we find that development of mobile medical apps is a worthwhile undertaking given their potential to improve outcomes for patients.
Journal
Clinical Pharmacology & Therapeutics – Wiley
Published: May 1, 2014